NICU Antibiotics and Outcomes (NANO) Follow-up Study
Conditions: Premature Birth; Antibiotics; Neurodevelopment Interventions: Drug: Ampicillin; Drug: Gentamicin; Drug: Placebo Sponsors: Sharp HealthCare; University of Pittsburgh; Morgan Stanley Children's Hospital; University of Louisville; Sharp Mary Birch Hospital for Women & Newborns; Children's Hospital of Philadelphia; Jefferson Medical College of Thomas Jefferson University; University of South Florida; Westchester Medical Center; Yale University; The University of Texas Health Science Center at San Antonio; Penn State University; State University of New York - Downstate Medical Center; Mount Sinai Hospital, Canada Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Canada Health | Children | Hospitals | Nanotechnology | Neurology | Neuroscience | New York University | Research | Science | Study | Texas University | Women